BRAIN RESOURCE LTD. right stock at the right time of a global depression & recession - Deutschemark - Seeking Alpha Brain Resource Ltd. is an Australia-based integrative neuroscience company. The Company is engaged in the provision of brain function analysis services. The Company's products include MyBrain Solutions, BRISC, WebNeuro, iSPOT and pharmaceutical trials. MyBrainSolutions provides the opportunity for employees, within 30 days of brief training sessions via the Internet, to enhance their positivity and increase their productivity at work. WebNeuro provides clinicians with more information than is currently available, to empower them with screening, diagnostic, treatment and monitoring decisions. Brain Resource International Database (BRISC) identifies core domains of brain health relating to both self-regulation and feelings. iSPOT is the current personalized medicine research study in mental health. The Company's wholly owned subsidiaries include BRC Operations Pty Ltd, BRC IP Pty Ltd, BRC Distribution Pty Ltd, BRC International Pty Ltd and BRC Development Pty Limited.
Numbers: Market Cap 19.7M AUD Sales 5.65M AUD (increase from 1.6M in 2005) Quarterly Revenue Growth -56% (that's why stock is at 0.21AUD or very cheap) EBIT 200,000 AUD (positive EBIT from 2009) Cash 8.4M AUD LT Debt 3.2M AUD Assets 29M AUD Liabilities 13M AUD Shares Outstanding 91,700,000 Float 40,700,000 Major Investors Spinite Pty Limited 16,700,000 Evian Gordon 11,350,000 Stuttgart Pty Limited 9,400,000 Dan Segal 6,350,000 Citigroup Nominees Pty Ltd 2,800,000 Dr. Chris Rennie 2,350,000 Red Star Development Pte Ltd 2,200,000 Link Traders (Australia) Pty Ltd 2,000,000 Professor Peter Robinson 1,800,000 Digue Pty Ltd 1,680,000 HSBC Custody Nominees Limited 1,550,000 King's College London 1,436,000 Krzysztof Kozek 1,150,000 Zandane Pty Ltd 1,017,000 RBC Dexia Inv.Serv. Aust. Nom. Pty Ltd 944,000 Natinal Nominees Pty Limited 816,000 Ceyx Holdings Pty Ltd 800,000 Stanlil Pty Ltd 775,000 Segal Super Pty Ltd 760,000 Professor Jim Wright 718,000
Resume: More and more people use antidepressants and go crazy, buying this stock you will make money from them going mad. Depression is the leading cause of disability in the US and is one of its most costly illnesses (85m clinical visits, costs more than $83bn p.a and 212 million antidepressant prescriptions in the US). Depression 15,000,000 affected ADHD 5,000,000 affected High insider ownership, stable balance sheet, more assets than total liabilities, booming industry. A WIN-WIN.
|